NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

NCT02669771

CompletedN/A

Sponsor: Astellas Pharma Inc

Conditions: Castration-resistant Prostate Cancer

Interventions: enzalutamide

Countries: Japan

The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.

Eligibility overview

Sex: MALE

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* no history of treatment with enzalutamide

Exclusion Criteria:

\-
Locations (47)
  • Numakunai, Iwate, Japan
  • Aichi, Japan
  • Akita, Japan
  • Aomori, Japan
  • Chiba, Japan
  • Ehime, Japan
  • Fukui, Japan
  • Fukuoka, Japan
  • Fukushima, Japan
  • Gifu, Japan
  • Gunma, Japan
  • Hiroshima, Japan
  • Hokkaido, Japan
  • Hyōgo, Japan
  • Ibaraki, Japan
  • Ishikawa, Japan
  • Kagawa, Japan
  • Kagoshima, Japan
  • Kanagawa, Japan
  • Kochi, Japan
  • Kumamoto, Japan
  • Kyoto, Japan
  • Mie, Japan
  • Miyagi, Japan
  • Miyazaki, Japan
  • Nagano, Japan
  • Nagasaki, Japan
  • Nara, Japan
  • Niigata, Japan
  • Okayama, Japan
  • + 17 more on CT.gov